Bio startup ArtBlood attracts $4.8 mn investment

Bio startup ArtBlood attracts $4.8 mn investment

South Korean bio startup ArtBlood, specializing in blood production for transfusion, announced on Tuesday that it successfully secured an investment...

Hyosung TNC to invest $1 bn in new bio-fiber plants in Vietnam

Hyosung TNC to invest $1 bn in new bio-fiber plants in Vietnam

Hyosung TNC Corp., the world’s top spandex maker, plans to invest $1 billion in new bio-textile materials plants in Vietnam to accelerate its ...

Samsung begins new drug development for rare diseases

Samsung begins new drug development for rare diseases

Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...

Reversing age possible in a decade: Harvard Prof. David Sinclair

Reversing age possible in a decade: Harvard Prof. David Sinclair

Humans will be able to control biological age and reverse their age in 10 years with advancements in medical science and live up to around 120, abou...

LG Chem reshuffles R&D unit to turn into EV materials maker

LG Chem reshuffles R&D unit to turn into EV materials maker

LG Chem Ltd., South Korea’s largest petrochemical company, is strengthening its research & development capabilities as it aims to transfor...

LG, Jackson Lab to jointly develop AI models for Alzheimer’s, cancers

LG, Jackson Lab to jointly develop AI models for Alzheimer’s, cancers

LG AI Research, the artificial intelligence research arm of South Korea’s LG Group, and the Jackson Laboratory (JAX), a US non-profit biomedic...

HD Hyundai Chemical to produce eco-friendly bio-naphtha

HD Hyundai Chemical to produce eco-friendly bio-naphtha

South Korea's HD Hyundai Chemical Co. announced on Thursday that it will collaborate with CJ CheilJedang Corp. to produce eco-friendly bio-naphtha...

Samsung targets gene therapy sector through US investments

Samsung targets gene therapy sector through US investments

Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is s...

LG Chem, CJ CheilJedang to launch eco-friendly bio-nylon joint venture

LG Chem, CJ CheilJedang to launch eco-friendly bio-nylon joint venture

South Korea’s top chemicals maker LG Chem Ltd. and food and biotechnology firm CJ CheilJedang Corp. have agreed to launch an eco-friendly bio-...

Samsung Biologics signs ADC CDO deal with LegoChem Bio

Samsung Biologics signs ADC CDO deal with LegoChem Bio

Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...

Cosmax opens integrated R&D center for bio-material

Cosmax opens integrated R&D center for bio-material

Cosmax Group, South Korea's largest cosmetics manufacturer specializing in original design manufacturing (ODM), announced on Monday that it has la...

Celltrion, WuXi XDC to develop new antibody-drug conjugates

Celltrion, WuXi XDC to develop new antibody-drug conjugates

South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...

Lotte Biologics, NJ Bio to jointly develop ADC

Lotte Biologics, NJ Bio to jointly develop ADC

South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...

Biopharma M&As: Next big thing for South Korean manufacturers

Biopharma M&As: Next big thing for South Korean manufacturers

When Orion Corp., known for its signature snack cake Choco-Pie, announced a $415 million deal to acquire biotech startup LegoChem Biosciences Inc. l...

DeepBrain AI launches deepfake detection solution

DeepBrain AI launches deepfake detection solution

South Korean AI startup DeepBrain AI announced on Friday that it released the country's first service-as-a-software (SaaS)-based deepfake detection ...

LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal

LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal

LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...

AI, cloud to rule video surveillance market in 2024: Hanwha Vision

AI, cloud to rule video surveillance market in 2024: Hanwha Vision

Hanwha Vision Co., formerly Hanwha Techwin, expects the global video surveillance market to undergo a major upgrade with the development of artifici...

Samsung launches new growth engine control tower at mobile division

Samsung launches new growth engine control tower at mobile division

Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, has created a business control tower within its Digital eX...

LegoChem Bio mulls name change after defeat to Lego

LegoChem Bio mulls name change after defeat to Lego

South Korean biopharmaceutical company LegoChem Biosciences Inc. is seeking to change its name after it lost in a trademark infringement lawsuit fil...

Access Bio opens second plant in New Jersey

Access Bio opens second plant in New Jersey

The US-based in-vitro diagnostic device company Access Bio Inc. announced on Monday that it opened its second factory in Monroe Township, New Jersey...

Korea to invest $200 mn in new drugs, vaccines by 2028

Korea to invest $200 mn in new drugs, vaccines by 2028

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

LG Chem, SNU to jointly develop next-generation material

LG Chem, SNU to jointly develop next-generation material

South Korea's LG Chem Ltd. partnered with Seoul National University (SNU) to develop next-generation material technologies, including pivotal materi...

South Korean bio, pharma industry set to take leap

South Korean bio, pharma industry set to take leap

South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...

'World-class bispecific antibody technology of ABL Bio'

'World-class bispecific antibody technology of ABL Bio'

MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...

Samsung Engineering secures $349 mn bio plant deal

Samsung Engineering secures $349 mn bio plant deal

South Korea's Samsung Engineering secured a deal for the Songdo Bio Raw Material Plant construction project from the global life sciences and labora...

HD Hyundai Oilbank secures bio-based material supply network

HD Hyundai Oilbank secures bio-based material supply network

South Korea's HD Hyundai Oilbank announced on Tuesday it signed contracts with Indonesia's Korindo Group and Korea's LX International for the purcha...

Samsung Biologics partners with Europe's largest VC

Samsung Biologics partners with Europe's largest VC

Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...

VaxCell-Bio applies for approval of anti-cancer drug for dogs

VaxCell-Bio applies for approval of anti-cancer drug for dogs

South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...

Humedix gets gov't OK for trials of dementia candidate drug

Humedix gets gov't OK for trials of dementia candidate drug

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

Johnson & Johnson more interested in Korean bio startups

Johnson & Johnson more interested in Korean bio startups

Johnson & Johnson, a global pharmaceutical giant, showed more interest in South Korean bio startups with competitive innovation despite the rece...

LG expands appliance subscription service to Singapore South Korea’s EV sales jump, hinting at end to market slump Celltrion gains ground as one of most-prescribed drug suppliers in Italy NCSOFT surges past Krafton on robust Q2; high hopes for Aion 2 game release in H2 YNCC avoids default with $220 mn lifeline from DL Chemical, Hanwha